Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial (original) (raw)
Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo
Steven Hirsch
BMJ, 1973
View PDFchevron_right
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out- patients
Steven Hirsch
The British Journal of Psychiatry, 1979
View PDFchevron_right
Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit
Donald Klein
Comprehensive Psychiatry, 1975
View PDFchevron_right
Flupwenazine Decanoate in Acute and ~Ainten~Ce Therapy of Schizop~K~Nia
Massimo Carlo Mauri
1987
View PDFchevron_right
Fluphenazine decanoate in acute and maintenance therapy of schizophrenia
Massimo Carlo Mauri
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1987
View PDFchevron_right
Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression
Kenneth Subotnik, David Fogelson
Psychopharmacology, 2000
View PDFchevron_right
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities
LESLIE CITROME
Schizophrenia Research, 2010
View PDFchevron_right
Oral fluphenazine versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials
Muhammad Almerie
Revista Colombiana De Psiquiatria, 2007
View PDFchevron_right
Fluphenazine decanoate: a clinical problem?
Rich Lewine
American Journal of Psychiatry, 1989
View PDFchevron_right
Penfluridol in the treatment of newly admitted schizophrenic patients in a brief therapy unit
Guy Chouinard
American Journal of Psychiatry, 1976
View PDFchevron_right
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Nicola Maayan
The Cochrane database of systematic reviews, 2015
View PDFchevron_right
Depot fluphenazine decanoate and enanthate for schizophrenia (Review
Maurice Eisenbruch
View PDFchevron_right
Fluphenazine decanoate (timing of administration) for people with schizophrenia
Aisha Aljojo
Cochrane Database of Systematic Reviews, 2017
View PDFchevron_right
Penfluridol in the Maintenance Treatment of Schizophrenic Patients Newly Discharged from A Brief Therapy Unit
Guy Chouinard
The Journal of Clinical Pharmacology, 1977
View PDFchevron_right
Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder
Shigenori Tadokoro
Annals of General Psychiatry, 2011
View PDFchevron_right
Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression
Samuel Siris
Schizophrenia Research, 1988
View PDFchevron_right
Depot fluphenazine decanoate and enanthate for schizophrenia
Maurice Eisenbruch
Reviews, 2004
View PDFchevron_right
Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patients
Mohammad Al-Yamani
Journal of Pharmaceutical Sciences, 1990
View PDFchevron_right
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate
Jim Mintz
Schizophrenia Research, 2002
View PDFchevron_right
Studies on a Second Long-Acting Fluphenazine
MOHAMMED AMIN
American Journal of Psychiatry, 1965
View PDFchevron_right
Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol)
Nawras Alhalabi, Aisha Aljojo, Tawfik Rajab
Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol), 2017
View PDFchevron_right
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms
Stephan Ruhrmann
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007
View PDFchevron_right
Pharmacologic Treatment of Patients Hospitalized With the Diagnosis of Schizoaffective Disorder
David Benedek
The Journal of Clinical Psychiatry, 2001
View PDFchevron_right
The outcome of severe acute schizophrenic illnesses after one year
Chris Frith
The British Journal of Psychiatry, 1979
View PDFchevron_right
Pimozide in the treatment of newly admitted schizophrenic patients
Guy Chouinard
Psychopharmacology, 1982
View PDFchevron_right
Comparison Of Effect Of Addition Of Fluvoxamine Or Risperidone To Clozapine In Chronic Partially Responsive Schizophrenic Patients On Clinical Response, QTc interval And Lipid profile
Praveer Waradkar
International Journal of Pharmacological Research, 2016
View PDFchevron_right
Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia
Ljubomir Hotujac
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004
View PDFchevron_right
Occupancy of dopamine D1, D2 and serotonin2A receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol
Mathias Bartels
Psychopharmacology, 2006
View PDFchevron_right
Pharmacological treatment of hospitalised schizophrenic patients in Belgium
J. Peuskens
International Journal of Psychiatry in Clinical Practice, 2006
View PDFchevron_right
Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy
Zana Stanković
Vojnosanitetski pregled, 2013
View PDFchevron_right
Risperidone, Quetiapine, and Fluphenazine in the Treatment of Patients With Therapy-Refractory Schizophrenia
Marie Mackowick -MDH-
Clinical Neuropharmacology, 2005
View PDFchevron_right
Association between flupenthixol treatment and emergence of manic symptoms
Abraham Weizman
European Psychiatry, 2002
View PDFchevron_right
What we know and what we don't know about the treatment of schizoaffective disorder
Alessandra Nivoli
European Neuropsychopharmacology, 2011
View PDFchevron_right